ID   SYHM_HUMAN              Reviewed;         506 AA.
AC   P49590; B4DDY8;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   07-APR-2021, entry version 179.
DE   RecName: Full=Histidine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.21 {ECO:0000269|PubMed:21464306};
DE   AltName: Full=Histidine--tRNA ligase-like;
DE   AltName: Full=Histidyl-tRNA synthetase;
DE            Short=HisRS;
DE   Flags: Precursor;
GN   Name=HARS2; Synonyms=HARSL, HARSR, HO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=7755634; DOI=10.1006/bbrc.1995.1696;
RA   O'Hanlon T.P., Raben N., Miller F.W.;
RT   "A novel gene oriented in a head-to-head configuration with the human
RT   histidyl-tRNA synthetase (HRS) gene encodes an mRNA that predicts a
RT   polypeptide homologous to HRS.";
RL   Biochem. Biophys. Res. Commun. 210:556-566(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-444, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   VARIANTS PRLTS2 VAL-200 AND LEU-368, CHARACTERIZATION OF VARIANTS PRLTS2
RP   VAL-200 AND LEU-368, SUBUNIT, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, AND
RP   FUNCTION.
RX   PubMed=21464306; DOI=10.1073/pnas.1103471108;
RA   Pierce S.B., Chisholm K.M., Lynch E.D., Lee M.K., Walsh T., Opitz J.M.,
RA   Li W., Klevit R.E., King M.C.;
RT   "Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian
RT   dysgenesis and sensorineural hearing loss of Perrault syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:6543-6548(2011).
RN   [14]
RP   VARIANTS PRLTS2 GLN-46; GLU-58; LYS-87; CYS-150 AND GLN-327.
RX   PubMed=31449985; DOI=10.1016/j.ejmg.2019.103733;
RA   Karstensen H.G., Rendtorff N.D., Hindbaek L.S., Colombo R., Stein A.,
RA   Birkebaek N.H., Hartmann-Petersen R., Lindorff-Larsen K., Hoejland A.T.,
RA   Petersen M.B., Tranebjaerg L.;
RT   "Novel HARS2 missense variants identified in individuals with sensorineural
RT   hearing impairment and Perrault syndrome.";
RL   Eur. J. Med. Genet. 2019:103733-103733(2019).
CC   -!- FUNCTION: Mitochondrial aminoacyl-tRNA synthetase that catalyzes the
CC       ATP-dependent ligation of histidine to the 3'-end of its cognate tRNA,
CC       via the formation of an aminoacyl-adenylate intermediate (His-AMP).
CC       {ECO:0000269|PubMed:21464306}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-histidine + tRNA(His) = AMP + diphosphate + H(+) + L-
CC         histidyl-tRNA(His); Xref=Rhea:RHEA:17313, Rhea:RHEA-COMP:9665,
CC         Rhea:RHEA-COMP:9689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57595, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78527, ChEBI:CHEBI:456215; EC=6.1.1.21;
CC         Evidence={ECO:0000269|PubMed:21464306};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:21464306}.
CC   -!- INTERACTION:
CC       P49590; Q6RW13: AGTRAP; NbExp=3; IntAct=EBI-3909030, EBI-741181;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21464306}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49590-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49590-2; Sequence=VSP_055133;
CC   -!- TISSUE SPECIFICITY: A high level expression is seen in the heart,
CC       kidney and skeletal muscle while a lower level expression is seen in
CC       the brain and liver.
CC   -!- DISEASE: Perrault syndrome 2 (PRLTS2) [MIM:614926]: A sex-influenced
CC       disorder characterized by sensorineural deafness in both males and
CC       females and ovarian dysgenesis in females. Affected females have
CC       primary amenorrhea, streak gonads, and infertility, whereas affected
CC       males show normal pubertal development and are fertile.
CC       {ECO:0000269|PubMed:21464306, ECO:0000269|PubMed:31449985}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U18936; AAA73972.1; -; Genomic_DNA.
DR   EMBL; U18937; AAA73974.1; -; mRNA.
DR   EMBL; AK293390; BAG56899.1; -; mRNA.
DR   EMBL; AC116353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW62019.1; -; Genomic_DNA.
DR   EMBL; BC007680; AAH07680.1; -; mRNA.
DR   EMBL; BC014982; AAH14982.1; -; mRNA.
DR   CCDS; CCDS4238.1; -. [P49590-1]
DR   CCDS; CCDS64267.1; -. [P49590-2]
DR   PIR; I38913; I38913.
DR   PIR; I38915; I38915.
DR   RefSeq; NP_001265660.1; NM_001278731.1. [P49590-2]
DR   RefSeq; NP_001265661.1; NM_001278732.1.
DR   RefSeq; NP_036340.1; NM_012208.3. [P49590-1]
DR   SMR; P49590; -.
DR   BioGRID; 117006; 101.
DR   DIP; DIP-59626N; -.
DR   IntAct; P49590; 33.
DR   MINT; P49590; -.
DR   STRING; 9606.ENSP00000230771; -.
DR   iPTMnet; P49590; -.
DR   MetOSite; P49590; -.
DR   PhosphoSitePlus; P49590; -.
DR   BioMuta; HARS2; -.
DR   EPD; P49590; -.
DR   jPOST; P49590; -.
DR   MassIVE; P49590; -.
DR   MaxQB; P49590; -.
DR   PaxDb; P49590; -.
DR   PeptideAtlas; P49590; -.
DR   PRIDE; P49590; -.
DR   ProteomicsDB; 3907; -.
DR   ProteomicsDB; 56026; -. [P49590-1]
DR   Antibodypedia; 27080; 199 antibodies.
DR   DNASU; 23438; -.
DR   Ensembl; ENST00000230771; ENSP00000230771; ENSG00000112855. [P49590-1]
DR   Ensembl; ENST00000508522; ENSP00000423616; ENSG00000112855. [P49590-2]
DR   Ensembl; ENST00000645749; ENSP00000494296; ENSG00000112855. [P49590-1]
DR   GeneID; 23438; -.
DR   KEGG; hsa:23438; -.
DR   UCSC; uc003lgx.5; human. [P49590-1]
DR   CTD; 23438; -.
DR   DisGeNET; 23438; -.
DR   GeneCards; HARS2; -.
DR   GeneReviews; HARS2; -.
DR   HGNC; HGNC:4817; HARS2.
DR   HPA; ENSG00000112855; Low tissue specificity.
DR   MalaCards; HARS2; -.
DR   MIM; 600783; gene.
DR   MIM; 614926; phenotype.
DR   neXtProt; NX_P49590; -.
DR   OpenTargets; ENSG00000112855; -.
DR   Orphanet; 2855; Perrault syndrome.
DR   PharmGKB; PA29192; -.
DR   VEuPathDB; HostDB:ENSG00000112855.14; -.
DR   eggNOG; KOG1936; Eukaryota.
DR   GeneTree; ENSGT00390000005922; -.
DR   HOGENOM; CLU_025113_4_2_1; -.
DR   InParanoid; P49590; -.
DR   OMA; YQIQKVW; -.
DR   OrthoDB; 1065556at2759; -.
DR   PhylomeDB; P49590; -.
DR   TreeFam; TF300652; -.
DR   BRENDA; 6.1.1.21; 2681.
DR   PathwayCommons; P49590; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   BioGRID-ORCS; 23438; 342 hits in 999 CRISPR screens.
DR   GeneWiki; HARS2; -.
DR   GenomeRNAi; 23438; -.
DR   Pharos; P49590; Tbio.
DR   PRO; PR:P49590; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P49590; protein.
DR   Bgee; ENSG00000112855; Expressed in small intestine Peyer's patch and 228 other tissues.
DR   ExpressionAtlas; P49590; baseline and differential.
DR   Genevisible; P49590; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:WormBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004821; F:histidine-tRNA ligase activity; IDA:WormBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:WormBase.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006427; P:histidyl-tRNA aminoacylation; IDA:WormBase.
DR   GO; GO:0006412; P:translation; NAS:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00773; HisRS-like_core; 1.
DR   CDD; cd00859; HisRS_anticodon; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR036621; Anticodon-bd_dom_sf.
DR   InterPro; IPR015807; His-tRNA-ligase.
DR   InterPro; IPR041715; HisRS-like_core.
DR   InterPro; IPR004516; HisRS/HisZ.
DR   InterPro; IPR033656; HisRS_anticodon.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   Pfam; PF13393; tRNA-synt_His; 1.
DR   PIRSF; PIRSF001549; His-tRNA_synth; 1.
DR   TIGRFAMs; TIGR00442; hisS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Deafness; Disease variant; Ligase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Protein biosynthesis; Reference proteome; Transit peptide.
FT   TRANSIT         1..33
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..506
FT                   /note="Histidine--tRNA ligase, mitochondrial"
FT                   /id="PRO_0000136336"
FT   REGION          131..133
FT                   /note="L-histidine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   REGION          331..332
FT                   /note="L-histidine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   BINDING         158
FT                   /note="L-histidine"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   BINDING         174
FT                   /note="L-histidine"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   BINDING         178
FT                   /note="L-histidine"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   BINDING         327
FT                   /note="L-histidine"
FT                   /evidence="ECO:0000250|UniProtKB:P12081"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         444
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         37..61
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055133"
FT   VARIANT         46
FT                   /note="L -> Q (in PRLTS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31449985"
FT                   /id="VAR_083046"
FT   VARIANT         58
FT                   /note="K -> E (in PRLTS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31449985"
FT                   /id="VAR_083047"
FT   VARIANT         87
FT                   /note="R -> K (in PRLTS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31449985"
FT                   /id="VAR_083048"
FT   VARIANT         150
FT                   /note="R -> C (in PRLTS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31449985"
FT                   /id="VAR_083049"
FT   VARIANT         200
FT                   /note="L -> V (in PRLTS2; the mutant protein is expressed,
FT                   can dimerize and localizes to the mitochondria; has
FT                   significantly decreased enzymatic activity compared to
FT                   wild-type; dbSNP:rs397515410)"
FT                   /evidence="ECO:0000269|PubMed:21464306"
FT                   /id="VAR_069532"
FT   VARIANT         327
FT                   /note="R -> Q (in PRLTS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31449985"
FT                   /id="VAR_083050"
FT   VARIANT         368
FT                   /note="V -> L (in PRLTS2; the mutant protein is expressed,
FT                   can dimerize and localizes to the mitochondria; has
FT                   significantly decreased enzymatic activity compared to
FT                   wild-type; dbSNP:rs376177973)"
FT                   /evidence="ECO:0000269|PubMed:21464306"
FT                   /id="VAR_069533"
SQ   SEQUENCE   506 AA;  56888 MW;  E1CE879837AE26E7 CRC64;
     MPLLGLLPRR AWASLLSQLL RPPCASCTGA VRCQSQVAEA VLTSQLKAHQ EKPNFIIKTP
     KGTRDLSPQH MVVREKILDL VISCFKRHGA KGMDTPAFEL KETLTEKYGE DSGLMYDLKD
     QGGELLSLRY DLTVPFARYL AMNKVKKMKR YHVGKVWRRE SPTIVQGRYR EFCQCDFDIA
     GQFDPMIPDA ECLKIMCEIL SGLQLGDFLI KVNDRRIVDG MFAVCGVPES KFRAICSSID
     KLDKMAWKDV RHEMVVKKGL APEVADRIGD YVQCHGGVSL VEQMFQDPRL SQNKQALEGL
     GDLKLLFEYL TLFGIADKIS FDLSLARGLD YYTGVIYEAV LLQTPTQAGE EPLNVGSVAA
     GGRYDGLVGM FDPKGHKVPC VGLSIGVERI FYIVEQRMKT KGEKVRTTET QVFVATPQKN
     FLQERLKLIA ELWDSGIKAE MLYKNNPKLL TQLHYCESTG IPLVVIIGEQ ELKEGVIKIR
     SVASREEVAI KRENFVAEIQ KRLSES
//
